The US Preventive Services Task Force (USPSTF) has released its final recommendations on screening for celiac disease. The Task Force concluded that there is not enough evidence to weigh the balance of the benefits and harms of screening for the disease in asymptomatic persons. More specifically, USPSTF stated:

• The evidence regarding the accuracy of screening for celiac disease is inadequate.
• The potential benefits and harms imposed on patients by screening vs not screening cannot be determined based on the available data.
• The available evidence is insufficient to determine if patients who have been screened positive for celiac disease would benefit or be harmed by treatment.

The USPSTF arrived at these conclusions after reviewing the scientific literature pertaining to screening of asymptomatic adults, teens, and children.